Genetic Technologies is a leader in the development and commercialisation of genetic risk assessment technology. Listed on the ASX (GTG) in and on NASDAQ. Investing in Genomics Stocks ; 1. Illumina · NASDAQ: ILMN. Illumina ; 2. Pacific Biosciences of California · NASDAQ: PACB. Pacific Biosciences Of California ; 3. On Monday, Genetic Technologies Ltd (GTG:ASX) closed at , % above its week low of , set on Aug 08, week range. Today. Aug 08 GENE - Genetic Technologies Limited - Depositary Receipt (Common Stock) Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqCM). Genetic Technologies Ltd. is a molecular diagnostics company, which engages in the provision of molecular risk assessment tests for cancer. It operates through.
Financial Performance. In , Genetic Technologies's revenue was million, a decrease of % compared to the previous year's million. Losses were. Value Proposition. Genetic Technologies is turning cutting-edge science into personalized, predictive tests driven by AI and machine learning. In addition to. Genetic Technologies Ltd GENE:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date09/15/23 · 52 Week Low The upside potential (average analyst target price relative to current price) of GENE is greater than % of all US stocks. Genetic Technologies Ltd's. Track Genetic Technologies Ltd. (GENE) Stock Price, Quote, latest community messages, chart, news and other stock related information. Stock analysis for Genetic Technologies Ltd (GENE:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company. Genetic Technologies Ltd. ADR ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range - Genetic Tech Spn ADR (GENE) ; Price/Book ; Price/Earnings ttm ; Most Recent Earnings N/A on N/A ; Latest Earnings Date 08/29/23 ; Annual Dividend & Yield N. See charts, data and financials for Genetic Technologies Ltd. - ADR GENE. Genetic Technologies Ltd. ADR · AT CLOSE PM EDT 09/05/24 · USD · % · Volume5, HELP CHANGE LIVES · American Gene Technologies is on the cusp of a cure for HIV. · American Gene Technologies is building a gene therapy platform to cut the time.
Overall, Genetic Technologies Limited (ADR) stock has a Value Grade of A, Growth Grade of D, Momentum Grade of F. Whether or not you should buy Genetic. Genetic Technologies shares soar 51%. BOSTON (MarketWatch) -- Genetic Technologies Ltd. shares soared 51% to $ on Thursday. Shares of the Australian. What Is the Genetic Technologies Ltd Stock Price Today? The Genetic Technologies Ltd stock price today is What Is the Stock Symbol for Genetic. Genetic Technologies Ltd. engages in the provision of molecular risk assessment tests for cancer. It operates through,the EasyDNA, AffinityDNA. The Genetic Technologies Ltd stock price fell by % on the last day (Friday, 13th Sep ) from $ to $ It has now fallen 3 days in a row. During. Genentech, Inc. (itpl.site): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Genentech, Inc. | Nyse: DNA | Nyse. Genetic Technologies Ltd. engages in the provision of molecular risk assessment for cancer. It operates through the USA and Australia geographical segments. Genetic Technologies Ltd. engages in the provision of molecular risk assessment tests for cancer. It operates through the EasyDNA, AffinityDNA, and GeneType/. Get the latest updates on Genetic Technologies Ltd ADS (GENE) after hours trades, after hours share volumes, and more. Make informed investments with.
Genetic Technologies (GENE) stock is taking off on Friday as the company prepares for new cancer testing markets with a collaboration. Today's Biggest Pre-. Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians. All information about Genetech Technology (GENETEC) - stock price, quote chart, key statistics, dividends, company news and more. How much is Genetic Technologies - American Depositary Shares worth? GENE has a market cap of $ million. This is considered a Sub-Micro Cap stock. What is. Find the latest Genetic Technologies Ltd (GENE) stock quote, history, news and other vital information to help you with your stock trading and investing.
We are pioneers in hybridisation technology and a leading provider of clinical research and diagnostic solutions. Genetic Technologies is a World Leader in Genetic Risk Assessment. Our brand geneType offers integrated risk testing for a range of serious conditions. As of September Genetic Technologies has a market cap of $ Million. This makes Genetic Technologies the world's th most valuable company.